-
Immuno-genomic landscape of osteosarcoma
Study
EGAS00001004197
-
Mesothelioma Genomics Study - WGS tumour/normal pairs
Study
EGAS00001002299
-
Next_gen_seq_of_eye_cancers
Study
EGAS00001002309
-
Pediatric Low-Grade Glioma RNA and Targeted Sequencing
Study
EGAS00001004242
-
Sequencing of paediatric High Grade Gliomas and DIPG
Study
EGAS00001002314
-
Mutation signatures in melanocytic nevi reveal characteristics of defective DNA repair
Study
EGAS00001004274
-
Successful BRAF/MEK-inhibition in a young patient with BRAF V600E-mutated extrapancreatic acinar cell carcinoma (HIPO-021)
Study
EGAS00001004282
-
Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell RCC -- CA209-009
Study
EGAS00001004290
-
Genomic_landscape_of_liver_cirrhosis
Study
EGAS00001004329
-
Whole-genome and transcriptome sequencing of primary cutaneous CD8+ aggressive epidermotropic cytotoxic T-cell lymphoma
Study
EGAS00001004332
-
Dissecting intratumor heterogeneity of nodal B cell lymphoma on the transcriptional, genetic, and drug response level
Study
EGAS00001004335
-
Molecular determinants of response to PD-L1 blockade across tumor types
Study
EGAS00001004343
-
RNAseq on 20 samples of multiple myeloma patients and 3 normal plasma cells.
Study
EGAS00001004347
-
Molecular subsets in renal cancer determine outcome to checkpoint and angiogenesis blockade
Study
EGAS00001004353
-
Whole-exome sequencing of extranodal NK/T cell lymphoma
Study
EGAS00001004357
-
Whole genome sequencing of glioblastoma reveals enrichment of non-coding constraint mutations in known and novel genes
Study
EGAS00001004379
-
Bulk RNAseq gene expression of baseline tumors from metastatic urothelial bladder cancer patients (IMvigor210) and metastatic renal cell carcinoma (IMmotion150)
Study
EGAS00001004386
-
Whole exome sequencing (bam files) of 55 samples of myxofibrosarcoma and 44 matched pairs
Study
EGAS00001005442
-
ctDNA monitoring using patient-specific sequencing and integration of variant reads - Lung cohort
Study
EGAS00001004447
-
Initial whole genome sequencing of plasma cell neoplasms in First Responders exposed to the World Trade Center attack of September 11, 2001
Study
EGAS00001004467
-
Transcriptomic analysis of the Phase 3 COMPARZ clinical trial
Study
EGAS00001004534
-
Survival Benefit and Genetic Profile of Pemetrexed as Initial Chemotherapy in Selected Chinese Patients with Advanced Lung Adenocarcinoma
Study
EGAS00001004546
-
Super enhancers define regulatory subtypes and cell identity in neuroblastoma
Study
EGAS00001004551
-
Angiosarcoma_follow_up_study
Study
EGAS00001000405
-
Genomic profiling of paediatric high grade gliomas from the HERBY clinical trial
Study
EGAS00001002328